Uncover key drivers, emerging technologies, and competitive movements shaping the worker heat stress monitoring wearable market from 2026–2035 with trusted insights from The Business Research Company
Starting from its 2026 valuation, what market size is the Inactivated Influenza Vaccine Market expected to reach by 2030?
The inactivated influenza vaccine market has experienced substantial expansion in recent years. Its valuation is projected to ascend from $7.14 billion in 2025 to $7.72 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 8.2%. The historical increase can be ascribed to factors like a surge in seasonal influenza incidence, the enlargement of immunization programs, an enhanced consciousness of preventive healthcare, the continued availability of egg-based vaccine production, and the proliferation of public health initiatives.
The market for inactivated influenza vaccines is projected to experience substantial expansion in the coming years. This market is anticipated to reach $10.55 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 8.1%. Key factors driving this growth during the forecast period include a heightened emphasis on pandemic readiness, increased capital expenditure in cell-based and recombinant vaccine development, wider immunization programs for adults and seniors, greater acquisition of vaccines by governments, and advancements in vaccine production methods. Prominent trends expected in the forecast timeframe encompass the wider acceptance of quadrivalent influenza vaccines, a stronger emphasis on high-dose and adjuvanted vaccine formulations, the broadening of seasonal vaccination initiatives, a greater focus on optimizing the cold chain, and improved attention to the scalability of vaccine manufacturing.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24251&type=smp
What Drivers Are Driving Adoption Within The Inactivated Influenza Vaccine Market?
The anticipated expansion of government vaccination initiatives is projected to propel the growth of the inactivated influenza vaccine market in the future. These programs are growing due to heightened public health awareness among populations, which subsequently increases the demand for immunization services and motivates governments to enhance vaccine accessibility and outreach efforts. Government vaccination programs facilitate the provision of inactivated influenza vaccines by offering free or subsidized access to high-risk groups, thereby ensuring equitable immunization coverage and diminishing the burden of seasonal influenza. For instance, in December 2023, the National Health Service, a UK-based government agency, introduced an NHS vaccine strategy to meet immunization goals. This strategy encompasses plans for community-based vaccination services, specifically targeting underserved and marginalized groups. Therefore, the increasing government vaccination programs are fostering the expansion of the inactivated influenza vaccine market.
What Segments Are Included Within The Inactivated Influenza Vaccine Market?
The inactivated influenza vaccine market covered in this report is segmented –
1) By Type Of Vaccine: Trivalent Inactivated Influenza Vaccine (TIIV), Quadrivalent Inactivated Influenza Vaccine (QIIV)
2) By Application: Children, Adolescence, Adults, Elderly
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Public Health Clinics
4) By End-User: Healthcare Providers, Individuals, Government Organizations, Pharmaceutical Companies
Subsegments:
1) Trivalent Inactivated Influenza Vaccine (TIIV): Egg-based Trivalent Inactivated Influenza Vaccine, Cell-based Trivalent Inactivated Influenza Vaccine, Adjuvanted Trivalent Inactivated Influenza Vaccine, High-dose Trivalent Inactivated Influenza Vaccine
2) Quadrivalent Inactivated Influenza Vaccine (QIIV): Egg-based Quadrivalent Inactivated Influenza Vaccine, Cell-based Quadrivalent Inactivated Influenza Vaccine, Adjuvanted Quadrivalent Inactivated Influenza Vaccine, Recombinant Quadrivalent Inactivated Influenza Vaccine, Pediatric Quadrivalent Inactivated Influenza Vaccine
Which Trends Are Expected To Influence The Inactivated Influenza Vaccine Market In The Upcoming Years?
Major companies operating in the inactivated influenza vaccine market are concentrating on developing quadrivalent inactivated influenza vaccines to deliver more extensive protection against four strains of the influenza virus. A quadrivalent inactivated influenza vaccine is a flu injection designed to defend against four different flu viruses. For instance, in February 2025, Zydus Lifesciences, an India-based pharmaceutical company, introduced VaxiFlu-4, a quadrivalent inactivated influenza vaccine crafted to provide seasonal defense against four new virus strains. VaxiFlu-4 offers enhanced protection by encompassing both influenza A and B strains, thereby diminishing the likelihood of vaccine mismatch. The vaccine seeks to tackle seasonal flu outbreaks through an optimized immune response specifically adapted to regional epidemiological patterns.
Who Are The Prominent Global Companies Shaping The Inactivated Influenza Vaccine Market Landscape?
Major companies operating in the inactivated influenza vaccine market are Sanofi S.A., GlaxoSmithKline plc, CSL Limited, Viatris Inc., Zydus Lifesciences Limited, Sinovac Biotech Ltd., Bharat Biotech International Limited, Hualan Biological Bacterin Co. Ltd., Changchun Biological Products Co. Ltd., Dalian Aleph Biomedical Co. Ltd., Jiangsu GDK Biotechnology Co. Ltd., KM Biologics Co. Ltd., JoinHub Pharma, Seqirus (CSL Influenza Division), Serum Institute of India Pvt. Ltd., Biological E. Limited, Shenzhen Sanofi Pasteur Biologicals Co. Ltd., Beijing Tiantan Biological Products Co. Ltd., Wuhan Institute of Biological Products Co. Ltd., Lanzhou Institute of Biological Products Co. Ltd., Chengdu Institute of Biological Products Co. Ltd., Sinopharm CNBG, Takeda Pharmaceutical Company Limited, Pfizer
Access The Complete Report For Deeper Market Insights:
https://www.thebusinessresearchcompany.com/report/inactivated-influenza-vaccine-global-market-report
Which Region Currently Holds The Largest Share Of The Inactivated Influenza Vaccine Market?
North America was the largest region in the inactivated influenza vaccine market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the inactivated influenza vaccine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Inactivated Influenza Vaccine Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=24251&type=smp
Browse Through More Reports Similar to the Global Inactivated Influenza Vaccine Market 2026, By The Business Research Company
Ultraviolet Analyzer Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/ultraviolet-analyzer-global-market-report
Molecular Spectroscopy Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/molecular-spectroscopy-global-market-report
Process Spectroscopy Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/process-spectroscopy-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company